St. Louis Post-Dispatch: Mallinckrodt turned an old drug into a ‘cash cow,’ pumping price to $40,000 a vial, emails show
Washington,
October 2, 2020
He argued that Mallinckrodt had invested $660 million in improving manufacturing of the drug and in seeking evidence that Acthar works for many other uses that the FDA permits. |